SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Company Response from AYTU BIOPHARMA, INC (AYTU) (CIK 0001385818) (AYTU) — Oct 26, 2016

AYTU BIOPHARMA, INC (AYTU) (CIK 0001385818)
Date: Oct. 26, 2016 · CIK: 0001385818 · Accession: 0001144204-16-129654

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-213738

Date
October 26, 2016
Author
JOSEPH GUNNAR & CO., LLC
Form
CORRESP
Company
AYTU BIOPHARMA, INC (AYTU) (CIK 0001385818)

Letter

JOSEPH GUNNAR & CO., LLC

30 Broad Street, 11th Fl

New York, NY 10004

October 26, 2016

Via EDGAR Delivery

Securities and Exchange Commission

100 F Street, NE

Washington, D.C. 20549

Re: Aytu BioScience, Inc.

Registration Statement on Form S-1

Filed September 21, 2016

File No. 333-213738

Ladies and Gentlemen:

Pursuant to Rule 461 of the General Rules and Regulations of the U.S. Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”), we, the representative of the several underwriters (the “Representative”), hereby join in the request of the Company that the effective time of the above-referenced Registration Statement be accelerated so that it will be declared effective at 5:00 p.m. Eastern Time on Thursday, October 27, 2016, or as soon thereafter as practicable.

Pursuant to Rule 460 under the Securities Act, please be advised that during the period from October 11, 2016 to the date of this letter, we, acting on behalf of the several underwriters, distributed as many copies of the Preliminary Prospectuses, dated October 11, 2016 and October 25, 2016 as appears to be reasonable to secure adequate distribution of the Preliminary Prospectus.

Very truly yours,
JOSEPH GUNNAR & CO., LLC

Show Raw Text
CORRESP
1
filename1.htm

JOSEPH GUNNAR & CO., LLC

30 Broad Street, 11th Fl

New York, NY 10004

October 26, 2016

Via EDGAR Delivery

Securities and Exchange Commission

100 F Street, NE

Washington, D.C. 20549

 Re: Aytu BioScience, Inc.

Registration Statement on Form S-1

Filed September 21, 2016

File No. 333-213738

Ladies and Gentlemen:

Pursuant to Rule 461
of the General Rules and Regulations of the U.S. Securities and Exchange Commission under the Securities Act of 1933, as amended
(the “Securities Act”), we, the representative of the several underwriters (the “Representative”), hereby
join in the request of the Company that the effective time of the above-referenced Registration Statement be accelerated so that
it will be declared effective at 5:00 p.m. Eastern Time on Thursday, October 27, 2016, or as soon thereafter as practicable.

Pursuant to Rule
460 under the Securities Act, please be advised that during the period from October 11, 2016 to the date of this letter, we,
acting on behalf of the several underwriters, distributed as many copies of the Preliminary Prospectuses, dated October 11,
2016 and October 25, 2016 as appears to be reasonable to secure adequate distribution of the Preliminary Prospectus.

    Very truly yours,

    JOSEPH GUNNAR & CO., LLC

    By: /s/ Eric Lord

    Name: Eric Lord

        Title: Head of Investment

        Banking/Underwritings